Chunyan Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chunyan Li has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Jun Wu
Thrombosis Research Center, Beijing Jishuitan Hospital, Capital Medical University, Beijing, People's Republic of China
3 shared publications - Cuiying Liang
Department of Clinical Laboratory, Peking University Fourth School of Clinical Medicine, Beijing, 100035, China
2 shared publications - Kun Wang
Department of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University, Beijing, 100035, China
2 shared publications Shangqi Yin
Department of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University
2 shared publicationsWuzheng Liu
Department of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University
2 shared publications- Xinwei Zang
Cell Therapy Center, Beijing Municipal Geriatric Medical Research Center, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
2 shared publications
Latest Publications
- Open Access
- 16 February 2026
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 41 (1) , 2611582
Diethyl Phthalate (DEP) as a potential osteosarcoma risk factor: a multi-omics study integrating network Toxicology, single-cell RNA sequencing, and molecular docking
Diethyl phthalate (DEP), a common plasticiser and endocrine disruptor, has been linked to cancer, but its role in osteosarcoma (OS) remains unclear. This study integrated network toxicology, transcriptomics, protein-protein interaction (PPI) analysis, machine learning, molecular docking, molecular dynamics (MD), single-cell RNA sequencing (scRNA-seq), and external validation to investigate DEP-related mechanisms in OS. We identified 45 DEP-responsive genes enriched in extracellular matrix-related pathways. PPI network analysis revealed 11 hub genes, of which LASSO, SVM-RFE, and Boruta algorithms consistently prioritised P4HA2, COL18A1, and COL10A1. Docking and MD simulations supported stable binding of DEP to P4HA2 and COL18A1 via hydrogen bonds and hydrophobic interactions. scRNA-seq demonstrated celltype-specific expression of these genes. Validation cohorts confirmed their upregulation in OS, with AUC values up to 0.950. These findings suggest that DEP may promote OS progression by targeting extracellular matrix remodelling, offering new diagnostic biomarkers and hypothesis-generating evidence for environmental osteocarcinogenesis.
- 16 February 2026
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 41 (1) , 2611582
Open AccessDiethyl Phthalate (DEP) as a potential osteosarcoma risk factor: a multi-omics study integrating network Toxicology, single-cell RNA sequencing, and molecular docking
Diethyl phthalate (DEP), a common plasticiser and endocrine disruptor, has been linked to cancer, but its role in osteosarcoma (OS) remains unclear. This study integrated network toxicology, transcriptomics, protein-protein interaction (PPI) analysis, machine learning, molecular docking, molecular dynamics (MD), single-cell RNA sequencing (scRNA-seq), and external validation to investigate DEP-related mechanisms in OS. We identified 45 DEP-responsive genes enriched in extracellular matrix-related pathways. PPI network analysis revealed 11 hub genes, of which LASSO, SVM-RFE, and Boruta algorithms consistently prioritised P4HA2, COL18A1, and COL10A1. Docking and MD simulations supported stable binding of DEP to P4HA2 and COL18A1 via hydrogen bonds and hydrophobic interactions. scRNA-seq demonstrated celltype-specific expression of these genes. Validation cohorts confirmed their upregulation in OS, with AUC values up to 0.950. These findings suggest that DEP may promote OS progression by targeting extracellular matrix remodelling, offering new diagnostic biomarkers and hypothesis-generating evidence for environmental osteocarcinogenesis.
- 6 April 2025
- Published by Elsevier in International Journal of Cardiology
- Vol. 432, 133221
Reduced myocardial CARF and the underlying implications in left ventricular noncompaction cardiomyopathy
- 6 April 2025
- Published by Elsevier in International Journal of Cardiology
- Vol. 432, 133221
Reduced myocardial CARF and the underlying implications in left ventricular noncompaction cardiomyopathy
- Open Access
- 17 August 2024
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 19 (1) , 1-8
The reduced cortical bone density in vertebral bodies: risk for osteoporotic fractures? Insights from CT analysis
There is a corresponding increase in the prevalence of osteoporosis and related fractures with the aging population on the rise. Furthermore, osteoporotic vertebral compression fractures (OVCF) may contribute to higher patient mortality rates. It is essential to conduct research on risk factors for OVCF and provide a theoretical basis for preventing such fractures. We retrospectively recruited patients who had spine CT for OVCF or back pain. Demographic and CT data were collected. Quantitative computed tomography (QCT) software analyzed the CT data, using subcutaneous fat and paraspinal muscles as reference standards for BMD processing. BMD of cortical and cancellous bones in each patient’s vertebral body was determined. In this study, 144 patients were divided into non-OVCF (96) and OVCF (48) groups. Non-OVCF patients had higher cortical BMD of 382.5 ± 52.4 to 444.6 ± 70.1 mg/cm3, with T12 having the lowest BMD (p < 0.001, T12 vs. L2). Cancellous BMD ranged from 128.5 ± 58.4 to 140.9 ± 58.9 mg/cm3, with L3 having the lowest BMD. OVCF patients had lower cortical BMD of 365.0 ± 78.9 to 429.3 ± 156.7 mg/cm3, with a further decrease in T12 BMD. Cancellous BMD ranged from 71.68 ± 52.07 to 123.9 ± 126.2 mg/cm3, with L3 still having the lowest BMD. Fractured vertebrae in OVCF patients (T12, L1, and L2) had lower cortical bone density compared to their corresponding vertebrae without fractures (p < 0.05). T12 had the lowest cortical BMD and L3 had the lowest cancellous BMD in OVCF patients, with T12 also having the highest incidence of osteoporotic fractures. These findings suggest that reduction in cortical BMD has a greater impact on OVCF than reduction in cancellous BMD, along with biomechanical factors.
- 17 August 2024
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 19 (1) , 1-8
Open AccessThe reduced cortical bone density in vertebral bodies: risk for osteoporotic fractures? Insights from CT analysis
There is a corresponding increase in the prevalence of osteoporosis and related fractures with the aging population on the rise. Furthermore, osteoporotic vertebral compression fractures (OVCF) may contribute to higher patient mortality rates. It is essential to conduct research on risk factors for OVCF and provide a theoretical basis for preventing such fractures. We retrospectively recruited patients who had spine CT for OVCF or back pain. Demographic and CT data were collected. Quantitative computed tomography (QCT) software analyzed the CT data, using subcutaneous fat and paraspinal muscles as reference standards for BMD processing. BMD of cortical and cancellous bones in each patient’s vertebral body was determined. In this study, 144 patients were divided into non-OVCF (96) and OVCF (48) groups. Non-OVCF patients had higher cortical BMD of 382.5 ± 52.4 to 444.6 ± 70.1 mg/cm3, with T12 having the lowest BMD (p < 0.001, T12 vs. L2). Cancellous BMD ranged from 128.5 ± 58.4 to 140.9 ± 58.9 mg/cm3, with L3 having the lowest BMD. OVCF patients had lower cortical BMD of 365.0 ± 78.9 to 429.3 ± 156.7 mg/cm3, with a further decrease in T12 BMD. Cancellous BMD ranged from 71.68 ± 52.07 to 123.9 ± 126.2 mg/cm3, with L3 still having the lowest BMD. Fractured vertebrae in OVCF patients (T12, L1, and L2) had lower cortical bone density compared to their corresponding vertebrae without fractures (p < 0.05). T12 had the lowest cortical BMD and L3 had the lowest cancellous BMD in OVCF patients, with T12 also having the highest incidence of osteoporotic fractures. These findings suggest that reduction in cortical BMD has a greater impact on OVCF than reduction in cancellous BMD, along with biomechanical factors.
- Open Access
- 8 June 2024
- Published by Elsevier in Practical Laboratory Medicine
- Vol. 40, e00413
Unified calibration of D-dimer can improve the uniformity of different detection systems
- 8 June 2024
- Published by Elsevier in Practical Laboratory Medicine
- Vol. 40, e00413
Open AccessUnified calibration of D-dimer can improve the uniformity of different detection systems
- 23 May 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 561, 119721
Protein profile of circulating extracellular vesicles reveals biomarker candidates for diagnosis of post-traumatic deep vein thrombosis
- 23 May 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 561, 119721
Protein profile of circulating extracellular vesicles reveals biomarker candidates for diagnosis of post-traumatic deep vein thrombosis
- Open Access
- 18 July 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 109 (11) , 3679-3680
Quantization of extraoral free flap monitoring for venous congestion with deep learning integrated iOS applications on smartphones
An abstract is unavailable. This article is available as a PDF only.
- 18 July 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 109 (11) , 3679-3680
Open AccessQuantization of extraoral free flap monitoring for venous congestion with deep learning integrated iOS applications on smartphones
An abstract is unavailable. This article is available as a PDF only.